Veranex Blog

Commercialization

3 min read

Insights Into the Needs of Chinese Hospital Lab Customers

We recently analyzed a report prepared by Ding Xiang Yuan (abbreviated as DXY; Ding Xiang Yuan is one of the largest and most influential online...

Read More

2 min read

China Reveals Its 2025 Coverage Goals for Publicly Funded Healthcare

In September 2021, China’s National Healthcare Security Administration (NHSA), the government agent in charge of publicly funded healthcare announced...

Read More

1 min read

China Aims to Complete Transition to DRG Payment Model for Inpatient Care by 2024

In November 2021, the Chinese government announced its 3-year (2022-2024) payment reform plan with the end goal to fully implement a diagnosis...

Read More

4 min read

Is China a 300 Million or 1.4 Billion Healthcare Population Market?

A reflection on the 2019 capability development progress report of the county hospitals in China The Veranex (formerly Boston Healthcare Associates)...

Read More

2 min read

China Payment Reform: 2020 Update

The pilot of implementing a diagnosis related group (DRG) payment model to inpatient hospital care, a major initiative of China’s ongoing healthcare...

Read More

3 min read

DTx Part II: Building Evidence-Based Value Propositions for Digital Therapeutics

In DTx Part I: Identifying Optimal Payment Models for Digital Therapeutics we identified several potential payment models for monetizing the value of...

Read More

2 min read

DTx Part I: Identifying Optimal Payment Models for Digital Therapeutics

According to the Digital Therapeutics Alliance (DTA), digital therapeutics (DTx) are products that deliver “software-generated therapeutic...

Read More